about
Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2Lipopolysaccharide endotoxinsAn undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coliThe crystal structure of the endothelial protein C receptor and a bound phospholipidMolecular basis of thrombomodulin activation of slow thrombinThe structure of LpxD fromPseudomonas aeruginosaat 1.3 Å resolutionAspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibitionPathophysiology of the antiphospholipid syndromeEndothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosisImplication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainCorrelated motions and residual frustration in thrombin.A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium.Placental thrombomodulin expression in recurrent miscarriage.Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis.Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.Does thrombophilia testing help in the clinical management of patients?Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C.Tissue engineering of the lymphatic system.Thrombomodulin.Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease.Evaluation of marine brown algae and sponges from Brazil as anticoagulant and antiplatelet products.Secretion of human protein C in mouse milkA brief historical review of the waterfall/cascade of blood coagulation.The blood coagulation system as a molecular machine.Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in micePlasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.Biosynthesis, transport, and modification of lipid A.So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.The influence of biomaterials on endothelial cell thrombogenicityIdentification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndromeAntibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C.Redox-dependent impairment of vascular function in sickle cell disease.A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic ratsIs there an alternative to systemic anticoagulation, as related to interventional biomedical devices?alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1A priming dose of protons alters the early cardiac cellular and molecular response to (56)Fe irradiation.The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules.
P2860
Q24299161-526EF14F-2393-4D26-85FA-46F668AACA63Q24650970-1ACFE18D-2992-4D60-8C17-E8285AA7AFFBQ24654765-D465C7B9-5D47-4844-8B0C-A83519A682A3Q27639046-BA259CA9-AEEA-4915-8F61-19F3A6A37E6DQ27656902-6907BDFF-C50F-416C-A029-085C4BBD015BQ27671074-26FA15A1-49F2-4A03-B519-61A07C6DEB61Q28202709-4CEA1B32-DDF2-420F-9851-449214127945Q28267421-ABEE455E-BFA0-4067-BE61-94FA931414D1Q28346584-D29B83E7-B01A-4EF8-9C60-F3C47E936446Q28364683-71BC1F3D-F555-439E-A91D-ABAA8AC42EEAQ30155107-19BD90AD-DC95-4319-859E-A948010CEB01Q30975949-6E3515AE-96FF-46CA-AADC-F1B884C1D575Q33641736-72B35B22-BEE9-4BEA-AE30-BD098037873CQ34264585-68E48818-288D-46D4-8CCD-BB036CDA0A9BQ34378782-524224E8-EF68-4FF4-B11C-170A8DEEC792Q34579752-27A07174-1DC8-4A97-A2C1-D03572DA2EC6Q34810086-FE22696D-F92E-40D0-B3D0-AAE1E4F3B660Q34949496-D61D55A0-E508-4800-BC16-F4DEBFEC220EQ35051476-C2935DB1-FFFD-45ED-946D-6012C55A516FQ35181628-9E80EC37-C98E-4E78-9380-0B4AC21F6B4DQ35181703-50AA1938-358A-446E-B630-D588E438C30BQ35188265-DF553EB5-F2E2-425B-A355-471108DCB9EAQ35380644-315BEAE2-5001-4520-9627-E5221D3424D3Q35564946-D46E95C2-5062-47F9-BB63-AAF7E68244BFQ35591873-D7EF7AEC-3D6A-415B-8975-81D60E7B421EQ35616018-61780834-BD92-415D-8CD8-AF200D4FCDCEQ35688843-0B2C6AB8-68F1-4836-A40B-70822C4E4E56Q35723413-EA7B86CA-4017-4CAB-8174-CD73C8FD7DF4Q35746719-0273826E-ABFE-488E-B97E-B8BF68CA7411Q35748046-4CA8E525-003D-4ECC-BB54-5920F7431375Q35792945-EF692574-97F9-424E-AB77-A05276484FBAQ35945520-6209DD3C-72CC-49EF-9271-4C45B45D295DQ35946069-462C4DD8-1200-4229-A13A-9A562743E9F4Q35995065-3ACB4559-3BED-4FC1-8233-8A7EC303F883Q36274222-B1100B23-EFB0-4088-9F99-7E44A5F1DFD6Q36307139-84CC0CCC-58D8-4515-A037-0D3FDCAD60F9Q36412659-F364A763-2976-48E2-A332-B4CDBD62C612Q36639349-92B2A349-BD98-4979-8635-6E4D709EBCE7Q36661970-69BCE69A-2E29-4AFE-980B-5B66395C181CQ36694044-C46460A0-C622-41F1-B7AB-8F81D67327F6
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Regulation of blood coagulation.
@ast
Regulation of blood coagulation.
@en
type
label
Regulation of blood coagulation.
@ast
Regulation of blood coagulation.
@en
prefLabel
Regulation of blood coagulation.
@ast
Regulation of blood coagulation.
@en
P1476
Regulation of blood coagulation.
@en
P2093
P304
P356
10.1016/S0167-4838(99)00266-6
P407
P577
2000-03-01T00:00:00Z